Types of Drugs Based on Cancer Types
Recommended Article : 【Bioinformatics】 Table of Contents for Bioinformatics Analysis
Source: NCI 2020
a. Pharmacology
1. Lymphoma (30)
○ Ibritumomab tiuxetan (ZevalinⓇ)
○ Denileukin diftitox (OntakⓇ)
○ Brentuximab vedotin (AdcetrisⓇ)
○ Rituximab (RituxanⓇ)
○ Vorinostat (ZolinzaⓇ)
○ Romidepsin (IstodaxⓇ)
○ Bexarotene (TargretinⓇ)
○ Bortezomib (VelcadeⓇ)
○ Pralatrexate (FolotynⓇ)
○ Ibrutinib (ImbruvicaⓇ)
○ Siltuximab (SylvantⓇ)
○ Idelalisib (ZydeligⓇ)
○ Belinostat (BeleodaqⓇ)
○ Obinutuzumab (GazyvaⓇ)
○ Nivolumab (OpdivoⓇ)
○ Pembrolizumab (KeytrudaⓇ)
○ Rituximab & Hyaluronidase human (Rituxan Hycela™)
○ Copanlisib hydrochloride (Aliqopa™)
○ Axicabtagene ciloleucel (Yescarta™)
○ Acalabrutinib (CalquenceⓇ)
○ Tisagenlecleucel (KymriahⓇ)
○ Venetoclax (Venclexta™)
○ Mogamulizumab-kpkc (PoteligeoⓇ)
○ Duvelisib (Copiktra™)
○ Polatuzumab vedotin-piiq (Polivy™)
○ Zanubrutinib (Brukinsa™)
○ Tazemetostat hydrobromide (Tazverik™)
○ Selinexor (Xpovio™)
○ Tafasitamab-cxix (MonjuviⓇ)
○ Brexucabtagene autoleucel (Tecartus™)
2. Leukemia (27)
○ Tretinoin (VesanoidⓇ)
○ Imatinib mesylate (GleevecⓇ)
○ Dasatinib (SprycelⓇ)
○ Nilotinib (TasignaⓇ)
○ Bosutinib (BosulifⓇ)
○ Rituximab (RituxanⓇ)
○ Alemtuzumab (CampathⓇ)
○ Ofatumumab (ArzerraⓇ)
○ Obinutuzumab (GazyvaⓇ)
○ Ibrutinib (ImbruvicaⓇ)
○ Idelalisib (ZydeligⓇ)
○ Blinatumomab (BlincytoⓇ)
○ Venetoclax (Vendexta™)
○ Ponatinib hydrochloride (IclusigⓇ)
○ Midostaurin (RydaptⓇ)
○ Enasidenib mesylate (IdhifaⓇ)
○ Inotuzumab ozogamicin (BesponsaⓇ)
○ Tisagenledeucel (KymriahⓇ)
○ Gemtuzumab ozogamicin (Mylotarg™)
○ Rituximab & Hyaluronidase human (Rituxan Hycela™)
○ Ivosidenib (TibsovoⓇ)
○ Duvelisib (Copiktra™)
○ Moxetumomab pasudotox-tdfk (Lumoxiti™)
○ Glasdegib maleate (Daurismo™)
○ Gilteritinib (XospataⓇ)
○ Tagraxofusp-erzs (Elzonris™)
○ Acalabrutinib (CalquenceⓇ)
**3. Breast **(25)
○ Everolimus (AfinitorⓇ)
○ Tamoxifen (Nolvadex)
○ Toremifene (FarestonⓇ)
○ Trastuzumab (HerceptinⓇ)
○ Fulvestrant (FaslodexⓇ)
○ Anastrozole (ArimidexⓇ)
○ Exemestane (AromasinⓇ)
○ Lapatinib (TykerbⓇ)
○ Letrozole (FemaraⓇ)
○ Pertuzumab (PerjetaⓇ)
○ Ado-trastuzumab emtansine (KadcylaⓇ)
○ Palbociclib (IbranceⓇ)
○ Ribociclib (KisqaliⓇ)
○ Neratinib maleate (Nerlynx™)
○ Abemaciclib (Verzenio™)
○ Olaparib (Lynparza™)
○ Talazoparib tosylate (TalzennaⓇ)
○ Atezolizumab (TecentriqⓇ)
○ Alpelisib (PiqrayⓇ)
○ Fam-trastuzumab deruxtecan-nxki (EnhertuⓇ)
○ Tucatinib (Tukysa™)
○ Sacituzumab govitecan-hziy (Trodelvy™)
○ Pertuzumab
○ Trastuzumab
○ Hyaluronidase–zzxf (Phesgo™)
**4. Lung **(23)
○ Bevacizumab (AvastinⓇ)
○ Crizotinib (XalkoriⓇ)
○ Erlotinib (TarcevaⓇ)
○ Gefitinib (IressaⓇ)
○ Afatinib dimaleate (GilotrifⓇ)
○ Ceritinib (LDK378/Zykadia™)
○ Ramucirumab (CyramzaⓇ)
○ Nivolumab (OpdivoⓇ)
○ Pembrolizumab (KeytrudaⓇ)
○ Osimertinib (Tagrisso™)
○ Necitumumab (Portrazza™)
○ Alectinib (AlecensaⓇ)
○ Atezolizumab (TecentriqⓇ)
○ Brigatinib (Alunbrig™)
○ Trametinib (MekinistⓇ)
○ Dabrafenib (TafinlarⓇ)
○ Durvalumab (Imfinzi™)
○ Dacomitinib (VizimproⓇ)
○ Lorlatinib (LorbrenaⓇ)
○ Entrectinib (Rozlytrek™)
○ Capmatinib hydrochloride (Tabrecta™)
○ Ipilimumab (YervoyⓇ)
○ Selpercatinib (Retevmo™)
**5. Skin **(15)
○ Vismodegib (ErivedgeⓇ)
○ Sonidegib (OdomzoⓇ)
○ Ipilimumab (YervoyⓇ)
○ Vemurafenib (ZelborafⓇ)
○ Trametinib (MekinistⓇ)
○ Dabrafenib (TafinlarⓇ)
○ Pembrolizumab (KeytrudaⓇ)
○ Nivolumab (OpdivoⓇ)
○ Cobimetinib (Cotellic™)
○ Alitretinoin (PanretinⓇ)
○ Avelumab (BavencioⓇ)
○ Encorafenib (Braftovi™)
○ Binimetinib (MektoviⓇ)
○ Cemiplimab-rwlc (LibtayoⓇ)
○ Atezolizumab (TecentriqⓇ)
**6. Kidney **(13)
○ Bevacizumab (AvastinⓇ)
○ Sorafenib (NexavarⓇ)
○ Sunitinib (SutentⓇ)
○ Pazopanib (VotrientⓇ)
○ Temsirolimus (ToriselⓇ)
○ Everolimus (AfinitorⓇ)
○ Axitinib (InlytaⓇ)
○ Nivolumab (OpdivoⓇ)
○ Cabozantinib (Cabometyx™)
○ Lenvatinib mesylate (LenvimaⓇ)
○ Ipilimumab (YervoyⓇ)
○ Pembrolizumab (KeytrudaⓇ)
○ Avelumab (BavencioⓇ)
**7. Liver **(11)
○ Sorafenib (NexavarⓇ)
○ Regorafenib (StivargaⓇ)
○ Nivolumab (OpdivoⓇ)
○ Lenvatinib mesylate (LenvimaⓇ)
○ Pembrolizumab (KeytrudaⓇ)
○ Cabozantinib (Cabometyx™)
○ Ramucirumab (CyramzaⓇ)
○ Ipilimumab (YervoyⓇ)
○ Pemigatinib (Pemazyre™)
○ Atezolizumab (TecentriqⓇ)
○ Bevacizumab (AvastinⓇ)
**8. Colorectal **(10)
○ Cetuximab (ErbituxⓇ)
○ Panitumumab (VectibixⓇ)
○ Bevacizumab (AvastinⓇ)
○ Ziv-aflibercept (ZaltrapⓇ)
○ Regorafenib (StivargaⓇ)
○ Ramucirumab (CyramzaⓇ)
○ Nivolumab (OpdivoⓇ)
○ Ipilimumab (YervoyⓇ)
○ Encorafenib (Braftovi™)
○ Pembrolizumab (KeytrudaⓇ)
**9. Prostate **(8)
○ Cabazitaxel (JevtanaⓇ)
○ Enzalutamide (XtandiⓇ)
○ Abiraterone acetate (ZytigaⓇ)
○ Radium 223 dichloride (XofigoⓇ)
○ Apalutamide (Erleada™)
○ Darolutamide (NubeqaⓇ)
○ Rucaparib camsylate (Rubraca™)
○ Olaparib (Lynparza™)
**10. Bladder **(7)
○ Atezolizumab (TecentriqⓇ)
○ Nivolumab (OpdivoⓇ)
○ Durvalumab (Imfinzi™)
○ Avelumab (BavencioⓇ)
○ Pembrolizumab (KeytrudaⓇ)
○ Erdafitinib (Balversa™)
○ Enfortumab Vedotin-ejfv (Padcev™)
**11. Thyroid **(7)
○ Cabozantinib (CometriqⓇ)
○ Vandetanib (CaprelsaⓇ)
○ Sorafenib (NexavarⓇ)
○ Lenvatinib mesylate (LenvimaⓇ)
○ Trametinib (MekinistⓇ)
○ Dabrafenib (TafinlarⓇ)
○ Selpercatinib (Retevmo™)
12. Targeted therapy ＜ 5
○ gastric, cervical, ovarian, pancreatic, brain, head & neck, soft tissue sarcomam, MM, etc.
Input : 2021.12.19 22:43